Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Bill Allows Changes To Part D Protected Classes, Via Rule-Making

Executive Summary

The new statutory requirement that Medicare drug plans cover all drugs in protected drug classes includes a hint of possible flexibility for interested stakeholders - the designated groups could be expanded or subtracted, though only through a formal regulatory process

You may also be interested in...



Part D Protected Classes: Stakeholders Wary About “Expert Panel” Role

The roles of an outside contractor and expert panel in implementing Medicare Part D's policy on protected drug classes are sparking questions and concerns among stakeholders

Part D Protected Classes: Stakeholders Wary About “Expert Panel” Role

The roles of an outside contractor and expert panel in implementing Medicare Part D's policy on protected drug classes are sparking questions and concerns among stakeholders

CMS Opens Way To Add, Or Subtract, Protected Classes In Part D Formularies

CMS is creating a multi-step process that will give outside experts and the public a role in adding or subtracting "protected" drug classes in Medicare Part D, as well as making exceptions to the rule that all drugs must be covered in a protected class

Related Content

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel